Oral in vivo bactofection in dextran sulfate sodium treated female wistar rats

Folia Biologica

Volumn 58, Issue 3-4, 2010, Pages 171-176

  Pálffy, Roland ^a   Behuliak, Michal ^a   Gardlík, Roman ^a   Jáni, Peter ^b   Kádaši, L'udevít ^a   Turòa, Ján ^a   Celec, Peter ^a  

^a Faculty of Natural Sciences   (Slovakia)

^b Hospital Krnov   (Czech Republic)

Author keywords

Bactofection; Dextran sulfate sodium induced colitis; Monocyte chemoattractant protein 1; Plasmid gene therapy; Superoxide dismutase

Indexed keywords

CYTOKINE; DEXTRAN SULFATE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; COLITIS; DIARRHEA; FEMALE; GENE THERAPY; GENE TRANSFER; METABOLISM; METHODOLOGY; PLASMID; RAT; SALMONELLA TYPHIMURIUM; STOMACH JUICE; WISTAR RAT;

ANIMALS; COLITIS; CYTOKINES; DEXTRAN SULFATE; DIARRHEA; FEMALE; GASTROINTESTINAL CONTENTS; GENE THERAPY; GENE TRANSFER TECHNIQUES; PLASMIDS; RATS; RATS, WISTAR; SALMONELLA TYPHIMURIUM; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

RATTUS NORVEGICUS; SALMONELLA TYPHIMURIUM;

EID: 77957787584     PISSN: 00155497     EISSN: None     Source Type: Journal    
DOI: 10.3409/fb58_3-4.171-176     Document Type: Article

References (32)

1. AGHDASSI E., WENDLAND B. E., STEINHART A. H., WOL-MAN S. L., JEEJEEBHOY K., ALLARD J. P. 2003. Antioxidant vitamin supplementation in Crohn's disease decreases oxidative stress. A randomized controlled trial. Am. J. Gastroenterol. 98: 348-353.
2. BILLEREY-LARMONIER C., UNO J. K., LARMONIER N., MIDURA A. J., TIMMERMANN B., GHISHAN F. K.,KIELA P. R. 2008. Protective effects of dietary curcumin in mouse model of chemically induced colitis are strain dependent. Inflamm Bowel Dis. 14: 780-793.
3. CASTAGLIUOLO I.,BEGGIAO E.,BRUN P.,BARZON L.,GOUS-SARD S.,MANGANELLI R., GRILLOT-COURVALIN C., PALU G. 2005. Engineered E. coli delivers therapeutic genes to the colonic mucosa. Gene Ther. 12: 1070-1078.
4. DAMIANI C. R., BENETTON C. A., STOFFEL C., BARDINI K. C., CARDOSO V. H., DI GIUNTA G., PINHO R. A., DAL-PIZ-ZOL F., STRECK E. L. 2007. Oxidative stress and metabolism in animal model of colitis induced by dextran sulfate sodium. J. Gastroenterol Hepatol. 22: 1846-1851.
5. DARJI A., GUZMAN C. A., GERSTEL B.,WACHHOLZ P., TIM-MIS K. N.,WEHLAND J., CHAKRABORTY T.,WEISS S. 1997. Oral somatic transgene vaccination using attenuated S. typhimurium. Cell. 91: 765-775.
6. EGASHIRA K., ZHAO Q., KATAOKA C., OHTANI K., USUI M., CHARO I. F., NISHIDA K., INOUE S., KATOH M., ICHIKI T.,TAKESHITA A. 2002. Importance of monocyte chemoattractant protein-1 pathway in neointimal hyperplasia after periarterial injury in mice and monkeys. Circ. Res. 90: 1167-1172.
7. GAUDIO E., TADDEI G., VETUSCHI A., SFERRA R., FRIERI G., RICCIARDI G., CAPRILLI R. 1999. Dextran sulfate sodium (DSS) colitis in rats: clinical, structural, and ultrastructural aspects. Dig. Dis. Sci. 44: 1458-1475.
8. GRILLOT-COURVALIN C., GOUSSARD S., HUETZ F., OJCIUS D. M., COURVALIN P. 1998. Functional gene transfer from intracellular bacteria to mammalian cells. Nat. Biotechnol. 16: 862-866.
9. GRILLOT-COURVALIN C., GOUSSARD S., COURVALIN P. 2002. Wild-type intracellular bacteria deliver DNA into mammalian cells. Cell Microbiol. 4: 177-186.
10. HERFARTH H., GOKE M., HELLERBRAND C., MUHLBAUER M.,VOGL D., SCHOLMERICH J.,ROGLER G. 2003. Polymorphism of monocyte chemoattractant protein 1 in Crohn's disease. Int. J. Colorectal Dis. 18: 401-405.
11. HUDCOVIC T., STEPANKOVA R., KOZAKOVA H., HRNCIR T., TLASKALOVA-HOGENOVA H. 2007. Effects of monocolonization with Escherichia coli strains O6K13 and Nissle 1917 on the development of experimentally induced acute and chronic intestinal inflammation in germ-free immunocompetent and immunodeficient mice. Folia Microbiol. (Praha). 52: 618-626.
12. HUDCOVIC T., KOZAKOVA H., KOLINSKA J., STEPANKOVA R., HRNCIR T., TLASKALOVA-HOGENOVA H. 2008. Monocolonization with Bacteroides ovatus protects immunodeficient SCID mice from mortality in chronic intestinal inflammation caused by long-lasting dextran sodium sulfate treatment. Physiol. Res. 17: 17.
13. INOUE S., EGASHIRA K., NI W., KITAMOTO S., USUI M., OTANI K., ISHIBASHI M., HIASA K., NISHIDA K., TAKE-SHITA A. 2002. Anti-monocyte chemoattractant protein-1 gene therapy limits progression and destabilization of established atherosclerosis in apolipoprotein E-knockout mice. Circulation 106: 2700-2706.
14. JIANG Z., ZHAO P., ZHOU Z., LIU J., QIN L.,WANG H. 2007. Using attenuated Salmonella typhi as tumor targeting vector for MDR1 siRNA delivery. Cancer Biol. Ther. 6: 555-560.
15. KANAUCHI O., SERIZAWA I., ARAKI Y., SUZUKI A., ANDOH A., FUJIYAMA Y.,MITSUYAMA K., TAKAKI K., TOYONAGA A., SATA M.,.BAMBA T. 2003. Germinated barley foodstuff, a prebiotic product, ameliorates inflammation of colitis through modulation of the enteric environment. J. Gastroenterol. 38: 134-141.
16. KOUTROUBAKIS I. E., MALLIARAKI N., DIMOULIOS P. D., KARMIRIS K., CASTANAS E., KOUROUMALIS E. A. 2004. Decreased total and corrected antioxidant capacity in patients with inflammatory bowel disease. Dig. Dis. Sci. 49: 1433-1437.
17. MELGAR S., KARLSSON A., MICHAELSSON E. 2005. Acute colitis induced by dextran sulfate sodium progresses to chronicity in C57BL/6 but not in BALB/c mice: correlation between symptoms and inflammation. Am. J. Physiol. Gastrointest Liver Physiol. 288: G1328-1338. Epub 2005 Jan. 1326.
18. MELGAR S., KARLSSON L., REHNSTROM E., KARLSSON A., UTKOVIC H., JANSSON L., MICHAELSSON E. 2008. Validation of murine dextran sulfate sodium-induced colitis using four therapeutic agents for human inflammatory bowel disease. Int. Immunopharmacol. 8: 836-844. Epub 2008 Mar. 2007.
19. MULDER T. P., VERSPAGET H. W., JANSSENS A. R., DE BRUIN P. A., PENA A. S., LAMERS C. B. 1991. Decrease in two intestinal copper/zinc containing proteins with antioxidant function in inflammatory bowel disease. Gut 32: 1146-1150.
20. NAKANO S., OHARA S., KUBOTA T., SAIGENJI K., HOTTA K. 1999. Compensatory response of colon tissue to dextran sulfate sodium-induced colitis. J. Gastroenterol. 34: 207-214.
21. OKU T., IYAMA S., SATO T., SATO Y., TANAKA M., SAGAWA T., KURIBAYASHI K., SUMIYOSI T.,MURASE K.,MACHIDA T., OKAMOTO T., MATSUNAGA T., TAKAYAMA T., TAKA-HASHI M., KATO J., HAMADA H., NIITSU Y. 2006. Amelioration of murine dextran sulfate sodium-induced colitis by ex vivo extracellular superoxide dismutase gene transfer. Inflamm. Bowel Dis. 12: 630-640.
22. PAGLIA P.,MEDINA E., ARIOLI I., GUZMAN C. A., COLOMBO M. P. 1998. Gene transfer in dendritic cells, induced by oral DNA vaccination with Salmonella typhimurium, results in protective immunity against a murine fibrosarcoma. Blood 92: 3172-3176.
23. PALFFY R., GARDLIK R., HODOSY J., BEHULIAK M., RESKO P., RADVANSKY J., CELEC P. 2006. Bacteria in gene therapy: bactofection versus alternative gene therapy. Gene Ther. 13: 101-105.
24. PHYLACTOS A. C., FASOULA I. N., ARNAUD-BATTANDIER F.,WALKER-SMITH J. A., FELL J. M. 2001. Effect of enteral nutrition on antioxidant enzyme systems and inflammation in paediatric Crohn's disease. Acta Paediatr. 90: 883-888.
25. SCALDAFERRI F., FIOCCHI C. 2007. Inflammatory bowel disease: progress and current concepts of etiopathogenesis. J. Dig. Dis. 8: 171-178.
26. STEIDLER L., HANS W., SCHOTTE L., NEIRYNCK S., OBER-MEIER F., FALK W., FIERS W., REMAUT E. 2000. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science 289: 1352-1355.
27. STEVCEVA L., PAVLI P., BUFFINTON G., WOZNIAK A., DOE W. F. 1999. Dextran sodium sulphate-induced colitis activity varies with mouse strain but develops in lipopolysaccharide-unresponsive mice. J. Gastroenterol. Hepatol. 14: 54-60.
28. SUGIMOTO K., OGAWA A., MIZOGUCHI E., SHIMOMURA Y., ANDOH A., BHAN A. K., BLUMBERG R. S., XAVIER R. J.,MIZOGUCHI A. 2008. IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J. Clin. Invest. 118: 534-544.
29. WADA T., FURUICHI K., SAKAI N., IWATA Y.,KITAGAWA K., ISHIDA Y., KONDO T., HASHIMOTO H., ISHIWATA Y., MUKAIDA N., TOMOSUGI N.,MATSUSHIMA K., EGASHIRA K.,YOKOYAMA H. 2004. Gene therapy via blockade of monocyte chemoattractant protein-1 for renal fibrosis. J. Am. Soc. Nephrol. 15: 940-948.
30. WIRTZ S.,NEUFERT C.,WEIGMANN B.,NEURATHM. F. 2007. Chemically induced mouse models of intestinal inflammation. Nat Protoc. 2: 541-546.
31. WIRTZ S.,NEURATH M. F. 2007. Mouse models of inflammatory bowel disease. Adv. Drug Deliv. Rev. 59: 1073-1083.
32. ZHANG Y., ZHAO W., ZHANG H. J.,DOMANN F. E.,OBERLEY L. W. 2002. Overexpression of copper zinc superoxide dismutase suppresses human glioma cell growth. Cancer Res. 62: 1205-1212.